Ryan Chappelle Joins NovoPath as SVP of Sales, Citing Forward Innovation in Pathology Informatics and Cloud as Key Motivation

NovoPath, a leading provider of comprehensive laboratory information systems solutions, announced today that Ryan Chappelle has joined the company as its new Senior Vice President of Sales.

Ryan Chappelle brings over 20 years of experience in healthcare technology sales and management to his new role at NovoPath. Most recently, he served as Vice President of Sales at Sunquest, where he was responsible for driving the company’s revenue growth through strategic sales initiatives.

In his new role at NovoPath, Ryan Chappelle will be responsible for overseeing the company’s sales team and driving new business growth through the development and execution of effective sales strategies.

Chappelle’s decision to join NovoPath was motivated by the company’s forward-thinking approach to pathology informatics and cloud technology. He cited the company’s commitment to innovation and its focus on delivering comprehensive, integrated solutions that streamline laboratory workflows as key factors in his decision.

“I am thrilled to join NovoPath and work with a team that is truly dedicated to pushing the boundaries of what is possible in the field of pathology informatics,” Chappelle said. “I believe that our focus on innovation and our commitment to delivering integrated, SaaS-based LIS solutions will be a game-changer for our customers and the industry as a whole.”

NovoPath CEO, Promise Okeke, added: “We are excited to welcome Ryan to the NovoPath team. His extensive experience in healthcare technology sales and management, combined with his passion for innovation and his deep understanding of the pathology informatics landscape, make him the perfect fit for this role. We look forward to working with Ryan to drive continued growth and success for NovoPath.”

SourceNovoPath

Hot this week

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMedâ„¢ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.